These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 19054267

  • 1. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

  • 2. Cytokines and liver injury in chronic HCV genotype 4 infection.
    Zekry A.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):332-5. PubMed ID: 19335783
    [No Abstract] [Full Text] [Related]

  • 3. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M, Kotsafti A, Cardin R, Farinati F.
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
    Stankovic-Djordjevic D, Djordjevic N, Tasic G, Dinic M, Karanikolic A, Pesic M.
    J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I.
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 11. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 12. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O, Abdel-Hamid M, Ismail A, El Shabrawy L, Sidhom KF, El Badawy NM, Ghazal FA, El Daly M, El Kafrawy S, Esmat G, Loffredo CA.
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [Abstract] [Full Text] [Related]

  • 13. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
    Young KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL.
    J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
    [Abstract] [Full Text] [Related]

  • 14. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M, Lampertico P, Seletti C, Francesca Donato M, Ronchi G, del Ninno E, Colombo M.
    Cancer; 2003 Aug 01; 98(3):529-34. PubMed ID: 12879470
    [Abstract] [Full Text] [Related]

  • 15. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    Int J Oncol; 2006 Feb 01; 28(2):383-91. PubMed ID: 16391793
    [Abstract] [Full Text] [Related]

  • 16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 01; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
    Perrella O, Cuomo O, Sbreglia C, Monaco A, Gnarini MR, Gentile B, Perrella M, Perrella A.
    J Biol Regul Homeost Agents; 2009 Jun 01; 23(4):251-8. PubMed ID: 20003764
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.